Kenvue stock gains after court victory in case over Tylenol purported links to autism
skhoward Update 9:05pm: Adds Kenvue comment. Kenvue (NYSE:KVUE) rose 5% in after hours trading after a court ruled in it favor in a class action lawsuit alleging prenatal exposure to Tylenol may contribute to autism or attention-deficit…
